ACADIA Pharmaceuticals Inc. (ACAD) Stock

ACADIA Pharmaceuticals Inc. (ACAD) is a Healthcare stock trading at $21.61 (as of 2026-06-18), with a market capitalization of $3.67B and a trailing P/E of 9.5. Figures are sourced from first-party U.S. SEC EDGAR filings and market data.

ACADIA Pharmaceuticals Inc. develops and commercializes small-molecule therapies for central nervous system disorders. It markets NUPLAZID (pimavanserin) for hallucinations and delusions linked to Parkinson’s disease psychosis and has product candidates in clinical development for conditions including Alzheimer’s disease psychosis, Rett syndrome, and schizophrenia.

Valuation — source: SEC EDGAR (first-party)
Price$21.61
Market Cap$3.67B
P/E Ratio9.5
EV / EBITDA40.7
Price / Book2.89
Price / Sales3.30
DCF Value (model)$11.54
DCF Upside vs Price-46.6%
Profitability & Growth — source: SEC EDGAR
Revenue (TTM)$1.07B
Net Margin36.5%
Return on Equity30.1%
Current Ratio3.59
Revenue Growth (YoY)9.7%
EPS Growth (YoY)-81.8%
FCF Growth (YoY)41.6%
Financial Health — source: SEC EDGAR
Altman Z-Score6.45 (safe)
Valuation vs Sector & Industry
Stock P/E9.5
Sector P/E (Healthcare)21.0
Industry P/E (Pharmaceutical Products)17.3
vs Sector-54.5%
vs Industry-44.7%
Smart-Money Activity — SEC Form 4 / 13F / Congressional disclosures
Top Institutional HolderBAKER BROS. ADVISORS LP ($954.88M)
Institutional Holders Tracked10
Company
SectorHealthcare
IndustryPharmaceutical Products
CEOCatherine E. Owen Adams
Employees653
CountryUS
IPO Date2005-03-18

Related Companies (Business model: Biotech (Clinical / Commercial-Stage); 8 closest by market cap; US-domiciled)

  • CRISPR Therapeutics AG (CRSP)
  • Scholar Rock Holding Corporation (SRRK)
  • Arrowhead Pharmaceuticals, Inc. (ARWR)
  • Alkermes plc (ALKS)
  • Indivior Pharmaceuticals Inc (INDV)
  • Crinetics Pharmaceuticals, Inc. (CRNX)
  • ADMA Biologics, Inc. (ADMA)
  • Mirum Pharmaceuticals, Inc. (MIRM)
ACAD earnings history · ACAD institutional & insider holders · Congress trades · Insider trades · Short interest · Stock screener

Data as of 2026-06-18.

Figures sourced from U.S. Securities and Exchange Commission (SEC EDGAR) filings and market data. Not personalized investment advice.